Literature DB >> 12471613

Quantification of expression of netrins, slits and their receptors in human prostate tumors.

Alain Latil1, Laurent Chêne, Béatrix Cochant-Priollet, Philippe Mangin, Georges Fournier, Philippe Berthon, Olivier Cussenot.   

Abstract

Recently, DCC (Deleted in Colorectal Cancer) protein has been forwarded as a receptor for netrin. The Netrin/DCC complex is critical for axon guidance and cell migration. In the developing nervous system, netrin protein secreted by midline cells attracts commissural axons by activating the DCC receptor on growth cones. This attraction can be switched to repulsion or silenced completely, depending on the DCC binding partner. The potential suppressor function of DCC in prostate tumorigenesis, through a still unknown mechanism, prompted us to quantify the expression of several genes involved in this axon guidance pathway. The relative expression levels of DCC, NEO1, NTN1, NTN2L, NTN4, UNC5C, Slit1, Slit2, Slit3, Robo1 and Robo2 were simultaneous quantified in 48 tumors and 7 normal prostate tissues by using real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). A reduction in DCC, NEO1, NTN1 and NTN4 expression was observed in prostate tumors, while many of the same prostate tumors over-expressed either Slit genes or their receptors, Robo. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12471613     DOI: 10.1002/ijc.10821

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  52 in total

1.  The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer.

Authors:  L Shan; L Ambroisine; J Clark; R J Yáñez-Muñoz; G Fisher; S C Kudahetti; J Yang; S Kia; X Mao; A Fletcher; P Flohr; S Edwards; G Attard; J De-Bono; B D Young; C S Foster; V Reuter; H Moller; T D Oliver; D M Berney; P Scardino; J Cuzick; C S Cooper; Y-J Lu
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-02-23       Impact factor: 5.554

2.  Alternatively spliced Robo2 isoforms in zebrafish and rat.

Authors:  Ertugrul Dalkic; Cem Kuscu; Ceren Sucularli; Iraz T Aydin; Kamil C Akcali; Ozlen Konu
Journal:  Dev Genes Evol       Date:  2006-04-20       Impact factor: 0.900

Review 3.  Slit-Robo interactions during cortical development.

Authors:  William D Andrews; Melissa Barber; John G Parnavelas
Journal:  J Anat       Date:  2007-06-06       Impact factor: 2.610

4.  Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion.

Authors:  Yu Hsuan Carol Yang; Jocelyn E Manning Fox; Kevin L Zhang; Patrick E MacDonald; James D Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-24       Impact factor: 11.205

5.  Therapeutic effects of topical netrin-4 in a corneal acute inflammatory model.

Authors:  Yun Han; Yi Shao; Ting-Ting Liu; Sang-Ming Li; Wei Li; Zu-Guo Liu
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

6.  Silymarin inhibited DU145 cells by activating SLIT2 protein and suppressing expression of CXCR4.

Authors:  Sedat Kacar; Nuriye Ezgi Bektur Aykanat; Varol Sahinturk
Journal:  Med Oncol       Date:  2020-02-15       Impact factor: 3.064

7.  Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.

Authors:  Punit Saraon; Natasha Musrap; Daniela Cretu; George S Karagiannis; Ihor Batruch; Chris Smith; Andrei P Drabovich; Dominique Trudel; Theodorus van der Kwast; Colm Morrissey; Keith A Jarvi; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

8.  SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium.

Authors:  Rebecca Marlow; Phyllis Strickland; Ji Shin Lee; Xinyan Wu; Milana Pebenito; Mikhail Binnewies; Elizabeth K Le; Angel Moran; Hector Macias; Robert D Cardiff; Saraswati Sukumar; Lindsay Hinck
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

9.  MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor.

Authors:  Jun Tie; Yanglin Pan; Lina Zhao; Kaichun Wu; Jie Liu; Shiren Sun; Xuegang Guo; Biaoluo Wang; Yi Gang; Yongguo Zhang; Quanjiang Li; Taidong Qiao; Qingchuan Zhao; Yongzhan Nie; Daiming Fan
Journal:  PLoS Genet       Date:  2010-03-12       Impact factor: 5.917

10.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.